Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 4Head & Neck 3Breast 3Gastrointestinal 2Tumor-Agnostic 1Thoracic 1Other hematologic neoplasm 1Other 1Lymphoid 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Uveal Melanoma 1

Interventions

Nivolumab 168Ipilimumab 152pembrolizumab 143Cyclophosphamide 126Interleukin-2 70aldesleukin 69fludarabine phosphate 68Radiotherapy 67Biopsy 53Temozolomide 48Blood Specimen Collection 45Peripheral Blood Stem Cell Transplantation 44fludarabine 43Radiosurgery 40trametinib 38Vemurafenib 36dabrafenib 33sargramostim 32Bevacizumab 31Aminolevulinic Acid 31Magnetic Resonance Spectroscopy 30Mycophenolic Acid 29Specimen Handling 28Whole-Body Irradiation 27Photochemotherapy 26Imiquimod 26CTLA-4 Antigen 26Busulfan 26Tacrolimus 25Surveys and Questionnaires 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Physical Examination × Dermatologic × Clear all
NCT06280040 2024-03-06

Longitudinal Follow-Up of Patients Treated With Hypofractionated Stereotactic Photon Radiotherapy Due to Uveal Melanoma

Medical University of Vienna

Unknown
20 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡